Treatment of heparin-induced thrombocytopenia by use of argatroban, a synthetic thrombin inhibitor.
about
Thrombotic complications in three hemodialysis patients with heparin-induced thrombocytopenia type INewer strategies for the treatment of heparin-induced thrombocytopenia.Anticoagulant-induced skin necrosis in a patient with hereditary deficiency of protein S.Danaparoid sodium.Argatroban for prevention and treatment of thromboembolism in heparin-induced thrombocytopenia.Heparin-induced thrombocytopenia and thrombosis syndrome: in vivo cross-reactivity with danaparoid and successful treatment with r-Hirudin.Pharmacotherapy of heparin- induced thrombocytopenia.Argatroban for heparin-induced thrombocytopenia in hepato-renal failure and CVVHD.Heparin-induced thrombocytopenia in a uremic patient requiring hemodialysis: an alternative treatment and reexposure to heparin.Management of uremic patients with heparin-induced thrombocytopenia requiring hemodialysis.Vitrectomy for Proliferative Diabetic Retinopathy in a Patient with Heparin-Induced Thrombocytopenia.Heparin-associated thrombocytopenia (HAT)--still a diagnostic and therapeutical problem in clinical practice.Heparin-induced thrombocytopenia with thrombosis: incidence, analysis of risk factors, and clinical outcomes in 108 consecutive patients treated at a single institution.The first report of successful carotid stent implant using argatroban anticoagulation in a patient with heparin-induced thrombocytopenia and thrombosis syndrome: a case report.Decreased argatroban clearance unaffected by hemodialysis in anasarca.
P2860
Q28167373-21B9B8D0-24D3-4414-8683-057F45D7FCAEQ33327972-0AD52C45-0ECB-404B-96C9-AA8E666F4A16Q33328121-47D9DDE6-338C-4A7F-A512-14EE83BE26CFQ33336359-D250F7D3-B12C-44BC-92DA-F7F79C9ED7B5Q33336836-9FEF9920-78FC-4648-8013-E08AE63F2D36Q33338766-F79BE58E-AE24-4AFE-A792-61168139B7EAQ33348283-74305C5A-5BF1-4592-9422-716A5F75E879Q33349541-A5A5060F-00D0-4C81-9BFD-A15E169564BCQ33375000-2AD8AACB-E7A0-46FF-AD44-51CE6C8B8FA2Q33378065-CEA1D514-E931-42B6-9EF1-E6A5AD6D3206Q33430422-CD9E9508-3F72-4584-8826-531D09B1FEB0Q33490154-9F79408B-64F3-40D2-BE2C-972F757532AAQ33500323-6BE8F545-3695-4C42-BC62-158FC73E18B7Q33501552-16D1E6DD-7644-40BA-A061-F3805877DAD1Q44551436-ABD4E8C6-1E9B-4D1C-A658-F706511C9EC8
P2860
Treatment of heparin-induced thrombocytopenia by use of argatroban, a synthetic thrombin inhibitor.
description
1992 nî lūn-bûn
@nan
1992 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Treatment of heparin-induced t ...... synthetic thrombin inhibitor.
@ast
Treatment of heparin-induced t ...... synthetic thrombin inhibitor.
@en
type
label
Treatment of heparin-induced t ...... synthetic thrombin inhibitor.
@ast
Treatment of heparin-induced t ...... synthetic thrombin inhibitor.
@en
prefLabel
Treatment of heparin-induced t ...... synthetic thrombin inhibitor.
@ast
Treatment of heparin-induced t ...... synthetic thrombin inhibitor.
@en
P2093
P1476
Treatment of heparin-induced t ...... synthetic thrombin inhibitor.
@en
P2093
P2860
P304
P356
10.1111/J.1365-2141.1992.TB06482.X
P407
P577
1992-11-01T00:00:00Z